Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
Conditions: Pneumonia, Ventilator-Associated; Pneumonia; Bloodstream Infection; Sepsis; Respiratory Distress Syndrome; Respiratory Tract Infections; Critical Illness Interventions: Drug: Oral Paste(0,5 g) containing 10 mg of polymyxin B, 10 mg of gentamycin and 150 mg of amphotericine B q6h; Drug: Suspension (10 ml) containing 100 mg of polymyxin B, 80 mg of gentamycin, 350 mg of amphotericine B and 500 mg of vancomycin q6h; Drug: Intravenous Antibacterial Agent - a 3-day course of systemic cefotaxime 1 g q6h or ceftriaxone 1 g qd Sponsor: MEDSI Clinical Hospital 1, ICU Not yet r...
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials
Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19
Conditions: Septic Shock; Endotoxemia; COVID; Corona Virus Infection; Sepsis, Severe Intervention: Device: Toraymyxin PMX-20R (PMX Cartridge) Sponsor: Spectral Diagnostics (US) Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2020 Category: Research Source Type: clinical trials
